For Patients With Gliomas, Radiopharmaceuticals Used To More Accurately Manage Treatment, Predict Survival

In the management of gliomas - or tumors that originate in the brain - precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall survival. Research published in the December issue of The Journal of Nuclear Medicine (JNM) highlights the potential of imaging with 3'-deoxy-3'-F-18-fluorothymidine (F-18-FLT) positron emission tomography (PET) to noninvasively and accurately provide tumor-specific details to guide management of patients with gliomas...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/0xVUXSEFazE/253555.php

sport news news auto sport